John Masiz Home Page

John Masiz, J.D. – Chairman, President, & CEO of BioChemics, Inc. (www.biochemics.com)

John Masiz has served as President, Chief Executive Officer and Chairman of BioChemics since 1989. From 1987 to 1990, John Masiz functioned as the Chief Operating Officer of Linsco Financial Group (now named LPL Financial), currently one of the largest private brokerage firms in the United States. From 1985 to1987, John Masiz was with Coopers & Lybrand. At Coopers & Lybrand, John Masiz was involved in strategic and tax consulting.  Before joining Coopers & Lybrand, Mr. Masiz served as a financial analyst with Hannaford Bros., Inc., This included its Shop & Save and Welby Drug groups. At Hannaford Bros., Mr. Masiz was a key team member on the development of the DSD (Direct Store Delivery) program the completely changed Hannaford’s approach to product distribution throughout its chain stores.  In addition, John Masiz developed an innovative cost/pricing model that restructured over $1 Billion in OTC and Consumer product store inventory and shelving mixes to maximize bottom line productivity.   John Masiz is a cum laude graduate of Colby College , with distinction in two majors. He received a Juris Doctorate degree from Suffolk University Law School and is a member of the Massachusetts Bar Association.

John Masiz Recent Press Releases:

Dr. R. Rox Anderson Joins BioChemics Scientific Advisory Board to Advise on Development of Dermatological Products.

Dr. Roy Altman Joins BioChemics Scientific Advisory Board to Advise on Clinical Development of Targeted Osteoarthritis Therapy.

BioChemics & Beth Israel Deaconess Medical Center Announce Wound Healing Research Collaboration.

Nanobac Pharmaceuticals, Inc. Announces Collaboration Agreement With BioChemics for Transdermal Therapeutic Formulation.